# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-122923
Filing Date
2024-04-29
Accepted
2024-04-29 17:25:42
Documents
23
Period of Report
2024-06-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d492136ddef14a.htm iXBRL | DEF 14A | 621926
6 | GRAPHIC | g492136g00a02.jpg | GRAPHIC | 22797
7 | GRAPHIC | g492136g00a03.jpg | GRAPHIC | 27686
8 | GRAPHIC | g492136g01n89.jpg | GRAPHIC | 30188
9 | GRAPHIC | g492136g15g15.jpg | GRAPHIC | 408464
10 | GRAPHIC | g492136g16g16.jpg | GRAPHIC | 211445
11 | GRAPHIC | g492136g46g01.jpg | GRAPHIC | 125060
12 | GRAPHIC | g492136g46g02.jpg | GRAPHIC | 116308
13 | GRAPHIC | g492136g47g01.jpg | GRAPHIC | 119211
14 | GRAPHIC | g492136g47g02.jpg | GRAPHIC | 119300
| Complete submission text file | 0001193125-24-122923.txt |  | 4055435

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | inva-20231231.xsd | EX-101.SCH | 4941
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | inva-20231231_def.xml | EX-101.DEF | 3974
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | inva-20231231_lab.xml | EX-101.LAB | 6670
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | inva-20231231_pre.xml | EX-101.PRE | 4273
26 | EXTRACTED XBRL INSTANCE DOCUMENT | d492136ddef14a_htm.xml | XML | 196328

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 24892947
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)